Syndicated Offerings

---

NetNog: #genesis® delivers syndicated, ethnographic-quality research, which includes elements of NetNog: #buy® and NetNog: #talk®. A NetNog: #genesis® research includes an executive summary, therapeutic overview, digital dashboard, consumer perspective, and implications.  

NetNog: #track™ is a syndicated, quarterly report that includes elements of NetNog: #buy®, NetNog: #talk®, and NetNog: #monitor®.  NetNog: #track™ analyzes disruptions in the market and tracks how the patient journey shifts within a specific therapeutic area.

NetNog: #genesis® Cystic Fibrosis is offered as a syndicated market research report. As of July 2020, NetNoggin® has updated NetNog: #genesis® Cystic Fibrosis to reflect changes due to TRIKAFTA. 

 NetNog: #genesis® NASH (including NAFL) is offered as a syndicated market research report and is available!

 NetNog: #genesis® Alzheimer's (including MCI) is offered as a syndicated market research report and is available! 

The executive summary highlights key findings, multi-media representations of the patient, and  common lexicon associated with the condition.

 Market overview critically reviews epidemiology, pathophysiology, and a patient journey as defined by guidelines. 

 Digital dashboard offers a summation of the digital landscape by analyzing conversation volumes by social channels and top posters. 

Using netnographic methodologies, NetNoggin® reports on patient and caregiver expressed journeys, outcomes, emotions, HCP interactions, resources, and more!

The implications section compares what should be happening (guidelines) in the market to patients/caregivers perspectives, as well as patient-expressed unmet needs.

After the purchase of NetNog: #genesis® research, NetNoggin® creates a customized presentation tailored to the needs and pain points of that specific company.